000177877 001__ 177877
000177877 005__ 20240229133753.0
000177877 0247_ $$2doi$$a10.3389/fimmu.2021.772588
000177877 0247_ $$2pmid$$apmid:34868037
000177877 0247_ $$2pmc$$apmc:PMC8636442
000177877 0247_ $$2altmetric$$aaltmetric:117185501
000177877 037__ $$aDKFZ-2021-02902
000177877 041__ $$aEnglish
000177877 082__ $$a610
000177877 1001_ $$aGuo, Cuncai$$b0
000177877 245__ $$aConserved Induction of Distinct Antiviral Signalling Kinetics by Primate Interferon Lambda 4 Proteins.
000177877 260__ $$aLausanne$$bFrontiers Media$$c2021
000177877 3367_ $$2DRIVER$$aarticle
000177877 3367_ $$2DataCite$$aOutput Types/Journal article
000177877 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1639053129_22604
000177877 3367_ $$2BibTeX$$aARTICLE
000177877 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000177877 3367_ $$00$$2EndNote$$aJournal Article
000177877 520__ $$aInterferon lambdas (IFNλ) (also known as type III IFNs) are critical cytokines that combat infection predominantly at barrier tissues, such as the lung, liver, and gastrointestinal tract. Humans have four IFNλs (1-4), where IFNλ1-3 show ~80%-95% homology, and IFNλ4 is the most divergent displaying only ~30% sequence identity. Variants in IFNλ4 in humans are associated with the outcome of infection, such as with hepatitis C virus. However, how IFNλ4 variants impact cytokine signalling in other tissues and how well this is conserved is largely unknown. In this study, we address whether differences in antiviral signalling exist between IFNλ4 variants in human hepatocyte and intestinal cells, comparing them to IFNλ3. We demonstrate that compared to IFNλ3, wild-type human IFNλ4 induces a signalling response with distinct magnitudes and kinetics, which is modified by naturally occurring variants P70S and K154E in both cell types. IFNλ4's distinct antiviral response was more rapid yet transient compared to IFNλ1 and 3. Additionally, divergent antiviral kinetics were also observed using non-human primate IFNλs and cell lines. Furthermore, an IFNλ4-like receptor-interacting interface failed to alter IFNλ1's kinetics. Together, our data provide further evidence that major functional differences exist within the IFNλ gene family. These results highlight the possible tissue specialisation of IFNλs and encourage further investigation of the divergent, non-redundant activities of IFNλ4 and other IFNλs.
000177877 536__ $$0G:(DE-HGF)POF4-316$$a316 - Infektionen, Entzündung und Krebs (POF4-316)$$cPOF4-316$$fPOF IV$$x0
000177877 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
000177877 650_7 $$2Other$$aIFNL4
000177877 650_7 $$2Other$$aantiviral
000177877 650_7 $$2Other$$ainterferon
000177877 650_7 $$2Other$$akinetics
000177877 650_7 $$2Other$$alambda
000177877 650_7 $$2Other$$asignalling
000177877 7001_ $$aReuss, Dorothee$$b1
000177877 7001_ $$aCoey, Jonathon D$$b2
000177877 7001_ $$aSukumar, Swathi$$b3
000177877 7001_ $$aLang, Benjamin$$b4
000177877 7001_ $$aMcLauchlan, John$$b5
000177877 7001_ $$0P:(DE-He78)4658b59d5b4e54b919fc63ab1213c78f$$aBoulant, Steeve$$b6$$udkfz
000177877 7001_ $$aStanifer, Megan L$$b7
000177877 7001_ $$aBamford, Connor G G$$b8
000177877 773__ $$0PERI:(DE-600)2606827-8$$a10.3389/fimmu.2021.772588$$gVol. 12, p. 772588$$p772588$$tFrontiers in immunology$$v12$$x1664-3224$$y2021
000177877 909CO $$ooai:inrepo02.dkfz.de:177877$$pVDB
000177877 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)4658b59d5b4e54b919fc63ab1213c78f$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000177877 9131_ $$0G:(DE-HGF)POF4-316$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vInfektionen, Entzündung und Krebs$$x0
000177877 9141_ $$y2021
000177877 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFRONT IMMUNOL : 2019$$d2021-01-29
000177877 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-01-29
000177877 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-01-29
000177877 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2021-01-29
000177877 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-01-29
000177877 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-01-29
000177877 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2021-01-29
000177877 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2021-01-29
000177877 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-01-29
000177877 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-29
000177877 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-29
000177877 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-01-29
000177877 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bFRONT IMMUNOL : 2019$$d2021-01-29
000177877 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2021-01-29
000177877 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2021-01-29
000177877 9201_ $$0I:(DE-He78)F140-20160331$$kF140$$lF140 Zelluläre Polarität und virale Infektion$$x0
000177877 980__ $$ajournal
000177877 980__ $$aVDB
000177877 980__ $$aI:(DE-He78)F140-20160331
000177877 980__ $$aUNRESTRICTED